Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENABLE study: effect of abiraterone on oxycodone pharmacokinetics
NL-OMON60714Phase 4Recruiting
- Sponsor
- Deventer Ziekenhuis
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of abiraterone and oxycodone in prostate cancer (PCa) (2 arms), sponsored by Deventer Ziekenhuis. Primary endpoints: Oxycodone Cmax, Oxycodone AUC0-8h and 1 more. Started Feb 2024; status: recruiting.
02
Drugs
abirateroneoxycodone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NL-OMON60714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60714.